Kamada Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“Previous animal studies have shown that AAT facilitates graft acceptance and survival, including prolongation of islet allograft by inhibiting inflammatory cytokines such as IL1B, IL6 and caspase 3.” Read the following article
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through two segments: Proprietary Products and Distribution. The Proprietary Products segment develops, manufactures and sells plasma-derived protein therapeutics products. The Distribution segment supplies plasma based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Ness Ziona, Israel. [Source: MarketWatch]
Company Website: http://www.kamada.com